Aspiriant LLC’s Vanguard Extended Market ETF VXF Stock Holding History

Aspiriant LLC’s Portfolio VXF Stock Details VXF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$862K	Buy	3,722 +42	+1%	+$10.1K	0.02%	186
2026 Q2	$906K	Hold	3,680	–	–	0.02%	180
2026 Q1	$757K	Hold	3,680	–	–	0.02%	179
2025 Q4	$770K	Sell	3,680 -2,113	-36%	-$444K	0.02%	175
2025 Q3	$1.21M	Hold	5,793	–	–	0.04%	134
2025 Q2	$1.12M	Buy	5,793 +2,113	+57%	+$375K	0.04%	142
2025 Q1	$634K	Hold	3,680	–	–	0.02%	169
2024 Q4	$699K	Hold	3,680	–	–	0.03%	167
2024 Q3	$670K	Sell	3,680 -10	-0.3%	-$1.75K	0.03%	170
2024 Q2	$623K	Hold	3,690	–	–	0.03%	174
2024 Q1	$647K	Hold	3,690	–	–	0.03%	170
2023 Q4	$607K	Hold	3,690	–	–	0.03%	176
2023 Q3	$529K	Hold	3,690	–	–	0.03%	172
2023 Q2	$549K	Buy	3,690 +10	+0.3%	+$1.4K	0.03%	173
2023 Q1	$516K	Hold	3,680	–	–	0.03%	172
2022 Q4	$489K	Sell	3,680 -11	-0.3%	-$1.49K	0.02%	181
2022 Q3	$469K	Buy	3,691 +11	+0.3%	+$1.55K	0.02%	173
2022 Q2	$482K	Hold	3,680	–	–	0.02%	168
2022 Q1	$610K	Sell	3,680 -1,203	-25%	-$198K	0.03%	162
2021 Q4	$893K	Buy	+4,883	New	+$918K	0.05%	145

Other funds holding VXF

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Gleason Group Prospect, Kentucky $1.13B AUM 12.68% 1-Year Est. Return

Van Cleef Asset Management Beachwood, Ohio $1.01B AUM 13.78% 1-Year Est. Return

Tenon Financial Metuchen, New Jersey $331M AUM 12.25% 1-Year Est. Return

James J. Burns & Company Melville, New York $937M AUM 13.35% 1-Year Est. Return

Act Wealth Management Plano, Texas $340M AUM 15.43% 1-Year Est. Return

HCR Wealth Advisors Los Angeles, California $1.27B AUM 24.42% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return

Legacy Private Trust Neenah, Wisconsin $1.83B AUM 13% 1-Year Est. Return

Aspiriant LLC's VXF Position: Q3 2026 in Review

Aspiriant LLC increased its Vanguard Extended Market ETF (VXF) stake by 1.1% in Q3 2026, buying an estimated $10.1K and bringing the position to 3,722 shares worth $862K. The position accounts for 0.02% of the portfolio, ranked #186.

Aspiriant LLC first reported a position in VXF in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.21M in Q3 2025. 332 funds tracked by Wall St. Rank hold VXF as of Q3 2026.

Aspiriant LLC held 3,722 shares of Vanguard Extended Market ETF worth $862K as of Q3 2026.
Aspiriant LLC bought 42 Vanguard Extended Market ETF shares in Q3 2026, an estimated $10.1K.
Vanguard Extended Market ETF made up 0.02% of Aspiriant LLC's portfolio in Q3 2026, its #186 holding.
Aspiriant LLC first reported a position in Vanguard Extended Market ETF in Q4 2021 and has held it in 20 quarters since.
Aspiriant LLC's Vanguard Extended Market ETF position peaked at $1.21M in Q3 2025.
332 funds tracked by Wall St. Rank held Vanguard Extended Market ETF as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.